Jeffrey M. Trent

Landscape of super-enhancers in small cell carcinoma of the ovary, hypercalcemic type and efficacy of targeting with natural product triptolide

D. Huntsman, V. Zismann, A. Karnezis, 2023, bioRxiv.

Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type

J. Trent, S. Leung, T. Nielsen, 2015, The Journal of pathology.

Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

J. Trent, D. Huntsman, G. Morin, 2018, Molecular Cancer Therapeutics.

Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial

Rebecca F. Halperin, S. Byron, D. Eslin, 2024, Genome medicine.